RadNet partners with Desert Oasis Healthcare to provide AI-enhanced breast cancer detection at no extra cost.
Key Details
- 1RadNet partners with Desert Oasis Healthcare to deploy Enhanced Breast Cancer Detection (EBCD) program.
- 2EBCD utilizes AI to identify suspicious breast areas possibly missed by radiologists.
- 3The program is now offered to Desert Oasis patients without extra fees; previously, there was up to a $60 out-of-pocket charge since its 2022 launch.
- 4AI-based EBCD users are 21% more likely to have breast cancer detected, per recent research.
Why It Matters
This partnership increases access to advanced AI-powered breast imaging for early cancer detection, eliminating cost barriers and potentially improving patient outcomes. Increased adoption and integration of imaging AI can accelerate early diagnosis and demonstrate real-world value in clinical practice.
Source
Radiology Business
Related News
•Radiology Business
New AI Flags Uncertainty in Breast Cancer Imaging Predictions
University of Pittsburgh researchers developed an AI model that quantifies uncertainty in breast cancer diagnostic predictions to enhance trustworthiness.
•Radiology Business
Webinar to Showcase Successful AI Automation in Radiology Workflows
A webinar will provide insights from imaging leaders on expanding and optimizing AI-driven automation in radiology clinical workflows.
•Radiology Business
Everlywell Launches Direct-to-Consumer Mammography AI for Breast Cancer Risk
Everlywell now offers the FDA-authorized Clairity Breast AI tool for patients to assess breast cancer risk from their mammograms.